InsiderTrades

Form 4 for PMVP PMV Pharmaceuticals, Inc.

Accepted 2021-07-14 00:00:00 ET · period of report 2021-07-13 · accession 0000899243-21-028387 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2021-07-14 2021-07-13 PMVP Kliman Gilbert H 10% J - Other $0.00 +28.2K 25.6K New $0
2021-07-14 2021-07-13 PMVP Kliman Gilbert H 10% J - Other $0.00 -500.0K 4.47M -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-13 J A 97,632 $0.00 97,632 I By: InterWest Management Partners X, LLC — — (F3) The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.
2 Common Common Stock 2021-07-13 J D 97,632 $0.00 0 I By: Khaled A. Nasr — — (F3) The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.
3 Common Common Stock 2021-07-13 J A 3,642 $0.00 4,201 I By: Keval Desai — — (F3) The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.
4 Common Common Stock 2021-07-13 J A 2,441 $0.00 2,816 I By Gilbert H. Kliman — — (F3) The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.
5 Common Common Stock 2021-07-13 J A 22,148 $0.00 25,552 I — —
6 Common Common Stock 2021-07-13 J D 500,000 $0.00 4,469,911 D By: InterWest Management Partners X, LLC — — (F3) The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.